As of March 2025 RVL Pharmaceuticals has a market cap of NZ$5.49 Million. This makes RVL Pharmaceuticals the world's 10310th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$5.49 M | -1.29% |
2024 | NZ$5.57 M | 12.13% |
2023 | NZ$4.96 M | -97.16% |
2022 | NZ$0.17 B | 32.8% |
2021 | NZ$0.13 B | -63.12% |
2020 | NZ$0.35 B | -33.63% |
2019 | NZ$0.53 B | -11.32% |
2018 | NZ$0.60 B |